Segment Analysis By Brand: Ozempics Diabetes Franchise Anchors Revenue While Wegovy Captures Obesity Growth Ozempic held a 65.31% brand share in 2025, underpinned by its 2017 launch and subsequent inclusion in cardiometabolic guidelines following the SUSTAIN-6 study, which showed a 26% reduction in cardiovascular events
AOD-9604 can be administered via subcutaneous injection or orally, depending on formulation
Most patients find their optimal maintenance between 1.0 and 2.4 mg weekly
Lilly introduced Mounjaro in Canada in late 2023, originally sold in single-dose weekly vials at a wholesale price of around $80 across six dosages
Below is a framework comparing theoretical transfer risk factors for common GLP-1 medications based on known pharmacokinetics and analogous drug classes
Ensuring adequate hydration is therefore an important consideration with GLP-1 RA treatment, as is recommended by the label, particularly for people with renal impairment, as dehydration is known to be associated with renal dysfunction [98]